Anthropic's IPO filing and its biotech acquisition lead the Silicon Valley feed

President Trump has announced that George Soros and his entire network will be investigated under RICO charges. He claims Soros is behind the funding, training, and radicalization of young people, fueling terror and extremism. https://t.co/vR2dHRUMwl

Anyone want to join a fun startup? I'm hiring!

this was easy to see coming for those able to step outside the bubble that is silicon valley

Unpopular opinion, but if your IPO filing says your product might end humanity, maybe you shouldn't be allowed to operate. https://t.co/nT68hTlSJA

I interviewed someone who created $25B worth of startup value over the past 25 years. The "Father of NYC tech" has also raised $2B in venture capital funding. His name is Kevin Ryan and here's what I learned:

JUST IN: US startup successfully produces the first ever gold grown in a laboratory

software engineers are going to have to tackle a new set of problems to unlock powerful multiagent systems to solve the world's hardest problems - right now is one of the most interesting moments in history to be an engineer. https://t.co/YsQ0xta4KR

Palmer Luckey unveils “Warhound,” a $200 million startup developing genetically enhanced dogs for the US military in partnership with Colossal Biosciences and Anduril Industries. Colossal will provide genetic engineering and cloning expertise, while Anduril will equip the dogs with advanced cybernetic technology and battlefield awareness systems. Follow: @AFpost

Surprise 1: Anthropic acquired a one-person biotech . . . Surprise 2: that person is me Surprise 3: I’m here to tell you all about it Yes, this is what you think it is; after 6 yrs of increasingly loose anonymity: the Professor Oak reveal post …and yes, it has gotten so boring around here that I’m literally doxxing myself to spice up the timeline ------- Ok, allow me to introduce myself. My name is Cody Tranbarger. I mostly tweet, but occasionally find time to dabble in drug dev & starting/building biotechs. My past lives span the VC, crossover, startup continuum; Prof Oak has been my way of keeping a digital foot in those worlds, despite having my physical feet planted elsewhere. The past 18 mo, ‘elsewhere’ was Mithril Medicine, a co. I founded to develop bsAbs for LAMA2-CMD & other ECM-related genetic diseases. Mithril was born out of hands-on building with @MikeNGladstone, @JasonPaulRhodes, @LifeSciVC, & team @atlasventure. Somehow, I made enough half-decent calls along the way (even a broken clock is right twice a day, eh?) to convince them Mithril/I warranted a small seed. While I can hardly rationalize such an outrageously cavalier bet, I’m grateful for it, & I'd partner with Atlas again in a heartbeat. In typical AV fashion, Mithril’s primordial form was virtual, decentralized, & ultra-lean. This stage tends to be short-lived, but for Mithril, it worked surprisingly well, for surprisingly long, thanks in part to the rapid maturation of the AI tools I used liberally. Eventually, Mithril became a bit of an experiment itself - to find the upper bound of how far it could scale as a single operator + a bunch of Claude (+ a stellar bench of part-time consultants). In parallel, I started spending time with @nc_frey, @an1lam, & @CoefficientBio team; and promptly experienced, for the 1st time, AI at the frontier. Soon thereafter, Mithril stopped looking like an experiment, & started looking like a preview of an entirely new operating model. From that spark came “Pipeline-in-a-Person.” The idea immediately resonated when we shared it here back in April; and it was central to the shared vision that led to Anthropic’s acquisition of Mithril, & my joining the team. Why join Anthropic? Three reasons. (1) For Mithril, the programs continue, with more resources & infrastructure behind them, and as much Claude as I can put to work. (2) For me, the chance to start several more programs, & find out how many one person can actually run in parallel - an almost unprecedented luxury for a curious drug hunter. (3) For our mission, a path to institutionalize & scale this new way of working, then put it in the hands of all of biopharma, all over the world - which, candidly, I find the most energizing. Will AI x Bio cure diseases? Unequivocally yes, imo… but not by the route that gets the most airtime. Rather than timeline acceleration & compression, I see orchestration & parallelization as today's low-hanging fruit. Most drug hunters see a handful of go/no-go calls in a career, & spend entirely too much of the rest trading emails (my inbox can attest). Give them the bandwidth to run several programs at once, and the time to focus on scientific judgment, and I’m willing to bet they’ll make better calls. And at scale, better calls translate to more drugs, higher hit rates, broader patient impact, & likely, a disease or 10 or 100 cured. I couldn't be more excited to build toward that future @AnthropicAI. Finally, a heartfelt thank you to BioTwitter/X. The end of anonymity is bittersweet, but if anyone’s earned a proper introduction, you all have. It’s difficult to overstate how much this app has done for me: a decade of education, plenty of friends, many job opportunities, several mentors, a few investors, even a co-founder (fmr). It was the generosity of this community that inspired me to start posting 6 years ago, after just as many years lurking. I hope I’ve been able to pay it forward, in my own small way. But, to be clear, Prof Oak isn’t going anywhere. Same beat, same themes, and now, a front-row seat to drug development at the frontier. Stay tuned for dispatches from the trenches; and remember... Gotta Cure 'Em All

• Right to live, work, study, retire in 30+ countries • Friction-free artist touring • 40 million pieces of paperwork per annum ditched • Mutual recognition of qualifications • Reliable multi-annual regional funding • A say on the rules our exporters already follow

JUST IN: Chinese AI startup Moonshot removes cyberattack training data from its latest Kimi model to prevent it from becoming a powerful hacking tool.

Secret's out! I've joined @FactoryAI as VP of Marketing to lead our new media and startup initiatives. Could not be more excited to work with this iconic team. BIG software factory girl. Look out for lots more soon, we are COOKING. ps: I'm hiring :) LFG https://t.co/LJDMDeIM2r

BREAKING - Anthropic files for an IPO https://t.co/0sh8uVl6Xd

As Anthropic's IPO nears its target date, it it worth remembering that IPOs get priced, and that as a young company with growing revenues and big losses, that pricing will be based on metrics that are buzzy and unfamiliar, from eyeballs in the dotcom era to users in the social media decade to ARR with AI companies...https://t.co/5DXmDGcSTf